Global Health Ltd. (MEDANT) Share Price Near 52-Week High as MEDANT Trades at Rs 1,521.15
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Global Health Ltd. Share Price is Rs 1,521.15, up Rs 14.40 or 0.96% from the previous close, and it is trading close to its 52-week high of Rs 1,525.65 as of 21 September 2026 at 2:18 PM IST. The company’s market capitalisation stands at Rs 40,512.26 crore. This makes Global Health Ltd. share price a live market update for investors tracking the stock’s yearly high zone on Univest.
The latest Univest figures show that MEDANT opened at Rs 1,400.90, moved within a range of Rs 1,400.90 to Rs 1,525.65, and last traded at Rs 1,521.15. The session confirms the price event, but it does not establish a company-specific catalyst. For readers searching Global Health Ltd. share price today, the key point is simple: the stock is trading just below its 52-week peak while healthcare sector valuation remains an important part of the discussion. Univest is tracking the move alongside the company’s fundamentals, peer ratios and sector benchmarks.
Global Health Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,521.15 |
| Previous Close | Rs 1,506.75 |
| Today's Move | +Rs 14.4 (+0.96%) |
| Open | Rs 1,400.9 |
| High | Rs 1,525.65 |
| Low | Rs 1,400.9 |
| Turnover | Rs 2.53 crore |
| Market Capitalisation | Rs 40,512.26 crore |
Global Health Ltd. (MEDANT) traded at Rs 1,521.15 versus the previous close of Rs 1,506.75, a rise of 0.96%. The stock opened at Rs 1,400.9, reached a high of Rs 1,525.65 and touched a low of Rs 1,400.9.
Global Health Ltd. share price today reflects a Rs 14.40 rise over the previous close of Rs 1,506.75. The stock opened at Rs 1,400.90, matched the day’s low at the same level, and reached a high of Rs 1,525.65 before last trading at Rs 1,521.15. Turnover stood at Rs 2.53 crore, which gives a factual read on traded value during the market window. The near-52-week-high event is clear because the current price is only Rs 4.50 below the one-year high, a difference of roughly 0.29% from the peak. That keeps Global Health Ltd. stock news focused on price behaviour around the yearly high rather than on any unverified trigger.
For readers following Global Health Ltd. share price live, the day’s move shows that MEDANT has stayed close to the upper end of its intraday range after opening well below the current level. The headline update matters because the stock is trading near its 52-week high while the broader market continues to watch healthcare counters for valuation and earnings context. Univest users tracking Global Health Ltd. share price update can compare the current market level with the company’s fundamentals and sector position.
Global Health Ltd. (MEDANT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 40,512.26 crore |
| P/E Ratio | 72.84x |
| P/B Ratio | 9.85x |
| ROE | 15.12% |
| ROCE | 19.38% |
| EPS | Rs 20.69 |
| Book Value Per Share | Rs 152.92 |
| Dividend Yield | 0.03% |
Global Health Ltd. (MEDANT) fundamental metrics show P/E 72.84x, P/B 9.85x, ROE 15.12%, ROCE 19.38%. These figures provide context only and are not a buy or sell signal.
Global Health Ltd. has a market capitalisation of Rs 40512.26 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 72.84x, P/B at 9.85x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.12% and ROCE of 19.38%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.69, book value per share of Rs 152.92, dividend yield of 0.03%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 44.56x, median ROE of 12.88%, median ROCE of 15.77%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 72.84x |
| Benchmark Median P/E | 44.56x |
| Benchmark Average P/E | 90.54x |
| Benchmark P/E Range | 0x to 1,595.77x |
| Company P/B Ratio | 9.85x |
| Benchmark Median P/B | 3.03x |
| Company ROE | 15.12% |
| Benchmark Median ROE | 12.88% |
| Company ROCE | 19.38% |
| Benchmark Median ROCE | 15.77% |
| Company Market Capitalisation | Rs 40,512.26 crore |
| Benchmark Median Market Cap | Rs 479.68 crore |
Global Health Ltd. (MEDANT) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Global Health Ltd. (MEDANT) has a P/E ratio of 72.84x, which is above the benchmark median of 44.56x, a difference of +63.46%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Global Health Ltd. (MEDANT) has a ROE of 15.12%, which is above the benchmark median of 12.88%, a difference of +17.39%. Global Health Ltd. (MEDANT) has a ROCE of 19.38%, which is above the benchmark median of 15.77%, a difference of +22.89%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Narayana Hrudayalaya Ltd. | NH | 39,436.53 | 48.32 | 8.31 | 19.86 | 16.2 |
| Krishna Institute of Medical Sciences Ltd | KIMS | 34,062.53 | 166.73 | 9 | 11.04 | 11.51 |
| Dr. Lal Pathlabs Ltd. | LALPATHLAB | 31,821.62 | 58.72 | 12.18 | 22.37 | 29.56 |
| Aster DM Healthcare Ltd. | ASTERDM | 65,885.36 | 206.74 | 15.58 | 13.07 | 16.22 |
| Fortis Healthcare Ltd. | FORTIS | 66,058.84 | 63.04 | 6.5 | 11.32 | 14.07 |
Global Health Ltd. (MEDANT) has a P/E ratio of 72.84x compared with the displayed peer median of 63.04x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.12% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 19.38% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Global Health Ltd. (MEDANT) has a market capitalisation of Rs 40,512.26 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Global Health Ltd.
- Global Health Ltd. Share Price is Rs 1,521.15, very close to the 52-week high of Rs 1,525.65.
- The day’s move is Rs 14.40, or 0.96%, versus the previous close of Rs 1,506.75.
- Market capitalisation stands at Rs 40,512.26 crore, placing the company well above the industry median.
- P/E is 72.84 and P/B is 9.85, both above the industry median and useful for valuation comparison.
- ROE of 15.12% and ROCE of 19.38% are both above the industry median for the same industry set.
About Global Health Ltd.
Global Health Ltd., listed as MEDANT, operates in the Healthcare sector and the Hospital & Healthcare Services industry. The stock is tracked on NSE and BSE under the company’s market identity used in Global Health Ltd. Share Price searches. Univest also tracks the company’s financial results, revenue trend, EPS, book value and other company financials for readers who follow Global Health Ltd. Latest News and Global Health Ltd. Company News. The company’s current market cap and valuation ratios keep it on the radar of investors who compare hospital and healthcare services stocks in India.
Frequently Asked Questions
Why is Global Health Ltd. Share Price near its 52-week high?
Ans. Global Health Ltd. Share Price is Rs 1,521.15 against a 52-week high of Rs 1,525.65. The price event is confirmed by the latest market data, but no company-specific catalyst is established in the figures.
What is Global Health Ltd. Share Price today?
Ans. Global Health Ltd. Share Price today is Rs 1,521.15, up Rs 14.40 or 0.96% from the previous close of Rs 1,506.75. The stock is trading close to its yearly high.
What is the market capitalisation of Global Health Ltd.?
Ans. Global Health Ltd. has a market capitalisation of Rs 40,512.26 crore. That is well above the industry median of Rs 479.68 crore for the same industry benchmark set.
How does Global Health Ltd. compare on valuation?
Ans. Global Health Ltd. trades at a P/E of 72.84 and a P/B of 9.85. Both are above the industry median, so the stock is valued at a premium to the central benchmark.
What do Global Health Ltd. EPS and book value show?
Ans. EPS is Rs 20.69 and book value per share is Rs 152.92. EPS shows earnings attributable to each share, while book value reflects the accounting net worth behind each share.
What does Global Health Ltd. ROE and ROCE indicate?
Ans. ROE is 15.12% and ROCE is 19.38%. Both stand above the industry median, which helps explain why Global Health Ltd. Share Price remains a closely watched healthcare name.
How does Global Health Ltd. compare with healthcare peers?
Ans. Global Health Ltd. has a market cap close to Narayana Hrudayalaya and above Dr. Lal Pathlabs and Rainbow Children’s Medicare. Its valuation is higher than some peers and lower than several others.
What should investors monitor in Global Health Ltd. Share Price?
Ans. Investors can monitor the stock’s position near its 52-week high, valuation ratios, quarterly revenue trend and sector benchmark comparison. These facts help frame Global Health Ltd. Share Price Today without assuming a catalyst.
Track Global Health Ltd. Share Price on Univest
Use Global Health Ltd. (MEDANT) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Global Health Ltd. Share Price on Univest for live updates on price, 52-week levels, market cap, P/E ratio, P/B ratio, ROE, ROCE, EPS and book value. Univest also helps users review Global Health Ltd. Share Price Today, healthcare peer comparison and broader stock news in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
